Пређи на садржај

Karoksazon

С Википедије, слободне енциклопедије
Karoksazon
IUPACime
2-(2-okso-4H-1,3-benzoksazin-3-il)acetamid
Klinički podaci
Kategorija trudnoće
  • ?
Način primeneOralno
Pravni status
Pravni status
  • ℞ (Prescription only)
Identifikatori
CAS broj18464-39-6ДаY
ATC kodnone
PubChemCID29083
ChemSpider27057
UNII807N226MNLДаY
Hemijski podaci
FormulaC10H10N2O3
Molarna masa206,20 g/mol
  • O=C(N)CN2C(=O)Oc1ccccc1C2

Karoksazon(Surodil,Timostenil) jeantidepresivkoji se nekad koristio za tretmandepresijeali više nije u prodaji.[1][2]On deluje kaoreverzibilniinhibitor monoaminske oksidaze(MAOI) oba podtipa:MAO-AiMAO-B,sa pet puta većom potentnošću na MAO-B.[3][4][5][6][7]

  1. ^Dictionary of organic compounds.London: Chapman & Hall. 1996.ISBN0-412-54090-8.
  2. ^Cecchini S, Petri P, Ardito R, Bareggi SR, Torriti A (1978). „A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline”.The Journal of International Medical Research.6(5): 388—94.PMID359383.
  3. ^Lieberman, A. N. (1994).Monoamine oxidase inhibitors in neurological diseases.New York: M. Dekker.ISBN0-8247-9082-0.
  4. ^Moretti A; Caccia C; Martini A; et al. (1981).„Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers”.British Journal of Clinical Pharmacology.11(5): 511—5.PMC1401585Слободан приступ.PMID7272163.
  5. ^Moretti A, Caccia C, Calderini G, Menozzi M, Amico A (1981). „Studies on the mechanism of action of caroxazone, a new antidepressant drug”.Biochemical Pharmacology.30(19): 2728—31.PMID6170295.doi:10.1016/0006-2952(81)90549-9.
  6. ^Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A (1981).„Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man”.British Journal of Clinical Pharmacology.11(6): 611—5.PMC1402186Слободан приступ.PMID7272178.
  7. ^Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E (1981).„Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man”.British Journal of Clinical Pharmacology.11(6): 605—10.PMC1402193Слободан приступ.PMID7272177.